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Abstract
Aims Intra-uterine growth restriction (IUGR) followed by accelerated postnatal growth is associated with an increased risk of
obesity and type 2 diabetes. We aimed to determine central and peripheral insulin sensitivity in mice that underwent IUGR
followed by postnatal catch-up growth and investigate potential molecular mechanisms underpinning their physiology.
Methods We used a C57BL/6J mouse model of maternal diet-induced IUGR (maternal diet, 8% protein) followed by cross-fostering
to a normal nutrition dam (maternal diet, 20% protein) and litter size manipulation to cause accelerated postnatal catch-up growth.We
performed intracerebroventricular insulin injection and hyperinsulinaemic–euglycaemic clamp studies to examine the effect of this
early nutritional manipulation on central and peripheral insulin resistance. Furthermore, we performed quantitative real-time PCR and
western blotting to examine the expression of key insulin-signalling components in discrete regions of the hypothalamus.
Results IUGR followed by accelerated postnatal growth caused impaired glucose tolerance and peripheral insulin resistance. In
addition, these ‘recuperated’ animals were resistant to the anorectic effects of central insulin administration. This central insulin
resistance was associated with reduced protein levels of the p110β subunit of phosphoinositide 3-kinase (PI3K) and increased
serine phosphorylation of IRS-1 in the arcuate nucleus (ARC) of the hypothalamus. Expression of the gene encoding protein
tyrosine phosphatase 1B (PTP1B; Ptpn1) was also increased specifically in this region of the hypothalamus.
Conclusions/interpretation Mice that undergo IUGR followed by catch-up growth display peripheral and central insulin resis-
tance in adulthood. Recuperated offspring show changes in expression/phosphorylation of components of the insulin signalling
pathway in the ARC. These defects may contribute to the resistance to the anorectic effects of central insulin, as well as the
impaired glucose homeostasis seen in these animals.
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Abbreviations
ARC Arcuate nucleus
EE Energy expenditure
GIR Glucose infusion rate
HFD High-fat diet
ICV Intracerebroventricular
IUGR Intra-uterine growth restriction
PI3K Phosphoinositide 3-kinase
POMC Pro-opiomelanocortin
PTP1B Protein tyrosine phosphatase 1B
PVH Paraventricular nucleus
RER Respiratory exchange ratio
SGA Small for gestational age
TBST Tris buffered saline with Tween 20
TDNMR Time-domain nuclear magnetic resonance
VMH Ventromedial nucleus
Introduction
Obesity and type 2 diabetes are increasing globally at an
unprecedented rate across all ages and sexes. Although a
genetic basis for obesity susceptibility is undisputed, only
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a small proportion of the BMI variation within the popu-
lation can be explained by known genetic variants, sug-
gesting there is an interaction between genetic factors and
the environment [1]. Evidence from clinical and experi-
mental studies shows that the risk of developing many
non-communicable diseases can be influenced by the
early-life environment [2, 3]. Numerous studies have
shown that low birthweight is associated with increased
risk of developing impaired glucose tolerance and, subse-
quently, type 2 diabetes [4, 5]. Furthermore, it is well
established that the accelerated growth that often follows
low birthweight, as well as accelerated postnatal growth
alone, are important risk factors for type 2 diabetes and
obesity [6, 7]. Indeed, the combination of low birthweight
with rapid weight gain, particularly if the baby crosses
growth percentiles, is strongly linked to developing type
2 diabetes and obesity later in life [8, 9].
Insulin signalling is essential for maintaining whole-
body energy homeostasis. The main sites of insulin action
in the periphery are muscle and adipose tissue, where
insulin increases glucose uptake; and liver, where insulin
decreases glucose production. As recognised more recent-
ly, insulin signalling in the central nervous system is es-
sential for maintaining energy homeostasis [10]. The hy-
pothalamus is the primary site of insulin action in the
brain [11]. In particular, agouti-related peptide/neuropep-
tide Y and pro-opiomelanocortin (POMC) neurons in the
arcuate nucleus (ARC), and steroidogenic factor 1 (SF1)
neurons in the ventromedial nucleus (VMH), have been
shown to be important for hypothalamic insulin signalling
[11, 12]. Neurons in the paraventricular (PVH) nucleus
are also capable of sensing insulin [13], although the rel-
evance of these neurons in maintaining glucose homeosta-
sis is unknown.
Infants born small for gestational age (SGA) display
defective insulin signalling in peripheral tissues, which
may contribute to their increased type 2 diabetes risk
[14, 15]. We have previously reported defects in the insu-
lin signalling pathway in peripheral tissues of rodents that
underwent IUGR followed by catch-up growth [16, 17]
and similar differences in adipose and muscle biopsies
from low-birthweight humans [14, 18]. Disrupted central
insulin signalling, particularly in the ARC, causes defects
in energy homeostasis, including disrupted glucose ho-
meostasis and obesity [19]. Therefore, altered central in-
sulin signalling may underlie the phenotypes reported in
individuals that experience IUGR followed by catch-up
growth. However, there are no studies that have yet ad-
dressed whether low birthweight followed by accelerated
postnatal growth leads to central insulin resistance. This is
not feasible to address in humans but can be analysed
using animal models, which may also be used to deter-
mine whether relationships are causal.
Therefore, the aim of the current study was to examine
whether murine offspring subjected to IUGR followed by
postnatal catch-up growth show altered central insulin sensi-
tivity, and to investigate the underlying molecular pathways
mediating any programmed effects.
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Methods
Animals This research has been regulated under the Animals
(Scientific Procedures) Act 1986 Amendment Regulations
2012 following ethical review by the University of Cambridge
Animal Welfare and Ethical Review Body. C57BL/6J mice
were purchased from Charles River (Harlow, UK). Female mice
were mated at 6 weeks old. Dams were randomised to either a
control diet (20% protein) or an isoenergetic low-protein diet
(8% protein) fed ad libitum during gestation and lactation. Diet
assignment was performed by an animal technicianwhowas not
involved in the outcome assessments.
Control and low-protein diets were from Arie Blok
(Woerden, the Netherlands) [16]. Cross-fostering was per-
formed at 3 days of age to establish two groups: control
(offspring born to and suckled by dams fed a control-diet)
and recuperated (offspring of low-protein-diet-fed dams
nursed by control-diet fed dams). To maximise the effects of
maternal nutritional differences on offspring postnatal growth
(and recapitulate low birthweight followed by accelerated
postnatal growth observed in humans), recuperated litters
were culled to four pups and control litters were culled to eight
pups on day 3. Body weights of animals were recorded at 3, 7,
14 and 21 days (control n = 30; recuperated n = 26) and week-
ly, thereafter (control n = 11; recuperated n = 8). Animals were
caged in groups of two littermates and maintained on a 12 h
light–dark cycle at 21–22°C with ad libitum access to chow
diet (LAD1; Special Diet Services, Crawley, UK) and water.
Ad libitum food intake in the home cage was measured week-
ly by calculating food consumed from food hoppers and the
measurements were used to calculate cumulative food intake
per mouse from 4–10 weeks of age. Because of the known
effects of female oestrogen levels on insulin sensitivity [20]
and the technical difficulties of oestrous cycle staging in mice,
only male offspring were studied. All assessments were con-
ducted at 12 weeks ± 3 days of age. For both groups, one male
mouse in each litter underwent a different experimental pro-
cedure: (1) hyperinsulinaemic–euglycaemic clamp and related
plasma analyses (control, n = 9; recuperated, n = 8); (2) body
composition analysis and plasma and tissue collection (con-
trol, n = 11; recuperated, n = 8); (3) intracerebroventricular
(ICV) insulin injection (control, n = 7; recuperated, n = 5);
(4) GTT (control, n = 11; recuperated, n = 6).
GTTMice were fasted for 16 h overnight and injected i.p. with
a 10% (wt/vol.) glucose solution at 1 g/kg body weight. Blood
glucose levels were measured from the tail vein using a hand-
held glucose monitor before and 15, 30, 60, 120 and 180 min
after glucose injection.
Hyperinsulinaemic–euglycaemic clamp After an overnight
fast, animals were anaesthetised with an i.p. injection (10 μl/
g) of Vetranquil (Novartis, Camberley, UK), Dormicum
(Roche, Burgess Hill, UK), fentanyl (Martindale Pharma,
Wooburn Green, UK) (VDF; 1:2:10 in 3 parts water) and the
tail vein was cannulated. Programmable ‘Aladdin’ syringe
pumps (World Precision Instruments, Hitchin, UK) were used
for automated infusions of glucose and insulin via the tail vein.
Blood glucose measurements and baseline blood samples
were taken at t = −10 and t = 0 min via tail bleed. The clamp
began with a primed-continuous (50 μl/h; 3.5 mU kg−1 min−1)
i.v. infusion of insulin (Actrapid, Novo Nordisk, Gatwick,
UK). During the 90 min insulin infusion, blood glucose was
measured every 5 min for the first 20 min and every 10 min
thereafter. To maintain euglycaemia relative to basal blood
glucose levels, a variable i.v. infusion of 12.5% (wt/vol.)
D-glucose was administered accordingly. The glucose infusion
rate (GIR; μl/h) was used as an indicator of peripheral insulin
action. Steady-state blood samples were taken at 10 min inter-
vals during the final 30 min (t = 70 to t = 90 min) of the clamp,
for determination of plasma glucose, insulin and NEFA.
Plasma analysis Blood samples were drawn from the tail tip
into heparin-coated capillary tubes, chilled on ice and centri-
fuged to separate out plasma. Commercially available kits
were used to determine plasma levels of insulin (Ultra-
sensitive mouse insulin ELISA, Crystal Chem, IL, USA)
and NEFA (Wako NEFA HR kit, Alphalabs, Eastleigh, UK).
TNFαwas measured by theMRCMDUMouse Biochemistry
Laboratory (Addenbrookes Hospital, Cambridge, UK). All
measurements were carried out as technical duplicates and
results were verified with a CVof <5%.
Body composition analysisBody composition was determined
at 09:00 in fed animals using time-domain nuclear magnetic
resonance (TDNMR; Minispec Plus, Bruker, Billerica, MA,
USA). Body weight was recorded before TDNMR for calcu-
lation of relative fat mass and lean mass.
Indirect calorimetry Mice were placed in a Meta-Trace
(Creative Scientific, UK) home cage measurement system
linked to a Minimox system developed in house (P.
Murgatroyd, Cambridge Institute of Metabolic Science and
NIHR/Wellcome Trust Clinical Research Facility,
Addenbrooke's Hospital, Cambridge, UK) to measure oxygen
consumption (VO
:
2) and carbon dioxide production (VCO2
:
).
Ventilation rates were 390 ml/min and samples were collected
every 18 min over 48 h. Energy expenditure (EE) was
analysed over a 24 h period, using the equation: EE (J) =
15.818 × VO
:
2 + 5.176 × VCO2
:
. The respiratory exchange ra-
tio (RER) was calculated as VCO2
:
/VO
:
2.
Lateral ventricle cannulation Mice were single-housed for
5 days prior to surgery and body weight recorded daily.
Mice were anaesthetised with a mix of inhaled isoflurane
and oxygen via nose cone and placed in a stereotactic device.
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A 26-gauge stainless-steel guide cannula (C315G-SPC;
Plastics One, Roanoake, VA, USA) was implanted into the
right lateral ventricle at +1.0 mm lateral, −0.5 mm caudal
and −2.0 mm ventral to the bregma, fixed to the skull with
cyanoacrylate adhesive and secured with dental cement
(Associated Dental Products, Swindon, UK). To prevent oc-
clusion, a dummy cannula (C315DC-SPC; Plastics One) was
fitted. All animals received subcutaneous analgesia and antibi-
otic (Rimadyl, 5 mg/kg; Terramycin LA, 60 mg/kg; both Pfizer,
Kent, UK). Bodyweight was monitored daily following surgery
and intracerebroventricular insulin injections, with subsequent
monitoring of food intake over a 20 h period, were performed 6–
7 days later, once pre-surgical body weight had been recovered.
Correct cannula placement was confirmed using an angiotensin-
II thirst test (human A9525, Sigma-Aldrich, Gillingham, UK;
200 ng dose in saline [154 mmol/l NaCl] vehicle) immediately
after the intracerebroventricular insulin injection experiment.
Only animals that showed a rapid dipsogenic response (drink
onset within 15 s to 3 min post injection) following angiotensin-
II injection were included in the analyses.
Intracerebroventricular insulin injection Two hours before the
onset of the dark period, food was removed from the cage and
insulin (Actrapid; diluted in saline to 0.2 μU/μl) was injected
into the lateral ventricle of awake, free-to-roam mice using a
Hamilton syringe (Sigma-Aldrich) attached to the indwelling
cannula. An insulin dose of 0.4 μU was selected based on trial
data and previous reports of insulin-induced inhibition of food
intake in mice [21, 22]. At the start of the dark period (18:00,
t = 0), a pre-weighed quantity of food was returned to the cage
and food intake was measured at t = 2, 4, 12 and 20 h following
food presentation. For comparison, baseline food intake mea-
surements were taken at the same time points the day prior to
insulin injection; the dummy cannula was manipulated (re-
moved and replaced) while mice were handled in the same
way as for the insulin injection process, except no injection
was performed. Pre-surgery food intake of single caged animals
was calculated for the 12 h period immediately prior to surgery.
RNA extraction, reverse transcription and quantitative PCR
Individual hypothalamic nuclei (ARC, PVH and VMH) were
microdissected from 1 mm-thick coronal sections of frozen
brains cut using a brain matrix (Braintree Scientific,
Braintree, MA, USA). After microdissection, RNA was ex-
tracted using RNeasy MinElute columns with on-column
DNase treatment according to the manufacturer’s instructions
(Qiagen, Manchester, UK), and RNAwas reverse transcribed
using a High-Capacity cDNA Reverse Transcription kit
(Thermo Fisher, Loughborough, UK). Insr, Irs1, P85α (also
known as Pik3r1) and Pik3cb mRNA expression was mea-
sured in technical duplicates using SYBR quantitative PCR
(Thermo Fisher). Irs2 and Ptpn1 (which encodes protein ty-
rosine phosphatase 1B [PTP1B]) mRNAwas measured using
TaqMan assay-on-demand (Irs2: Mm03038438_m1; Ptpn1:
Mm00448427_m1; both Thermo Fisher). Target gene expres-
sion was normalised to the housekeeping gene Sdha (expres-
sion of which did not differ between groups). All quantitative
PCR was performed using a StepOne Plus qPCR machine
(Thermo Fisher).
Protein extraction, SDS-PAGE and western blottingARC was
microdissected as above. Protein was extracted in lysis
buffer (50 mmol/l HEPES [pH 8], 150 mmol/l NaCl, 1%
(wt/vol.) Triton X-100, 1 mmol/l Na3VO4, 30 mmol/l
NaFl, 10 mmol/l Na4P2O7, 10 mmol/l EDTA (all Sigma-
Aldrich) and a 1:200 dilution of protease inhibitor cock-
tail set III [Merck-Millipore, Watford, UK]). Total protein
concentration of lysates was determined using a
bicinchoninic acid kit (Sigma-Aldrich) and samples dilut-
ed in Laemmli buffer. Samples (4 μg protein) were loaded
onto 8% polyacrylamide gels for electrophoresis and
transferred to a polyvinylidene difluoride (PVDF) mem-
brane (Merck-Millipore). The membrane was washed,
then stained with Ponceau red (Sigma-Aldrich). The
stained membrane was imaged and bands measured for
normalisation. Membranes were blocked in 5% (wt/vol.)
BSA in Tris buffered saline with Tween 20 (TBST),
followed by overnight incubation with the following pri-
mary antibodies: insulin receptor β subunit (sc-711, Santa
Cruz Biotechnology, Dallas, TX, USA; 1:200 dilution), p-
IRS1 Ser307 (07-247, Upstate Biotechnology, Lake
Placid, NY, USA; 1:1000 dilution) and phosphoinositide
3-kinase (PI3K) p110β (ab151549, Abcam, Cambridge,
UK; 1:1000 dilution). All antibodies were validated as
cross-reactive to mouse. Following 3 × 5 min washes in
TBST, membranes were incubated for 1 h in horseradish-
peroxidase (HRP)-linked secondary antibody (Abcam) di-
luted 1:10,000 in 5% BSA in TBST. Antibody binding
was detected using chemiluminescence substrate and the
ChemiDoc Imaging system (Bio-Rad, Hemel Hempstead,
UK). Protein abundance was quantified by band densi-
tometry using Image Lab 5.1 software (Bio-Rad) and nor-
malised to total transferred protein as visualised by
Ponceau stain.
Statistical analysis All data were analysed using Prism 7 soft-
ware (GraphPad, La Jolla, CA, USA). Values are expressed as
mean ± SEM. For data comparing one variable between off-
spring, an unpaired t test was used. In the ICV insulin injection
experiments, a paired t test was used to compare measure-
ments at baseline and after insulin injection from the same
animals. For experiments measuring data over time, a two-
way ANOVAwith repeated measures was used to determine
the overall effect of maternal diet and time. A Sidak post hoc
test was carried out if the overall p value for two-way ANOVA
was < 0.05.
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Results
Growth trajectory of recuperated offspring Recuperated off-
spring showed accelerated postnatal growth and were signifi-
cantly heavier than controls by the end of the first postnatal
week (Fig. 1a). Recuperated offspring remained significantly
heavier than controls throughout the remainder of the lactation
period (p < 0.001). However, there was no difference in body
weight between control and recuperated offspring from 4 to
12 weeks of age, or in whole-body fat mass as measured by
TDNMR (as a percentage of body weight) at 12 weeks of age
(Fig. 1b,c). Despite no change in overall adiposity, recuperat-
ed offspring had a significantly larger epididymal fat depot
than controls when expressed as a percentage of whole body
weight (p < 0.05; Fig. 1d).
To assess energy balance, ad libitum cumulative food in-
take per mouse in the home cage was measured weekly for the
period of 4–10 weeks of age. There was no difference in
cumulative food intake between control and recuperated off-
spring (Fig. 1e). At 12 weeks, EE was lower in recuperated
offspring compared with controls (p < 0.05; Fig. 1f). The RER
was also significantly lower in recuperated offspring com-
pared with controls (p < 0.05; Fig. 1g).
Recuperated offspring show reduced glucose tolerance and
insulin sensitivity Control and recuperated offspring
underwent an i.p. GTT at 12 weeks of age. There was an
overall effect of maternal diet on glucose levels during the test
(p < 0.001; Fig. 2a). Blood glucose was significantly higher in
recuperated animals 120 min following i.p. glucose injection
compared with controls (p < 0.05). Furthermore, recuperated
offspring had a significantly higher AUC over the course of
the GTT compared with controls (p < 0.05; Fig. 2b).
To determine whole-body insul in sensi t iv i ty,
hyperinsulinaemic–euglycaemic clamps were carried out
in offspring. Compared with baseline, in both groups,
plasma insulin levels increased significantly following in-
sulin infusion (control: 75.86 ± 6.90 to 901.70 ±
96.55 pmol/l; recuperated: 68.96 ± 10.34 to 665.50 ±
110.34 pmol/l; p < 0.01 compared with baselines).
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Fig. 1 Postnatal growth trajectory of control and recuperated offspring.
(a) Body weight, recorded on postnatal day 3, 7, 14 and 21. p < 0.001 for
overall effect of maternal diet and for overall effect of time, two-way
ANOVA. (b) Post-weaning body weight. (c) Fat mass (circles) and lean
mass (squares) of 12-week-old offspring as measured by TDNMR,
expressed as a percentage of total body weight. (d) Epididymal fat pad
weight of 12-week-old offspring, expressed as percentage of total body
weight. (e) Cumulative food intake of offspring from 4 to 10 weeks of
age. (f) EE over 24 h in offspring at 12 weeks of age. (g) RER of offspring
at 12 weeks of age. Solid line/white symbols, control; dashed line/black
symbols, recuperated. In (a), control n = 30, recuperated n = 26; in (b–g),
control n = 11, recuperated n = 8. In (a), **p < 0.01, ***p < 0.001, post
hoc test, recuperated vs control; in (c, d, f, g), *p < 0.05, t test. Recup,
recuperated
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Plasma glucose levels were not significantly different at
baseline and hyperinsulinaemic steady states in control or
recuperated groups (Fig. 2c). There was a significant ef-
fect of maternal diet on GIR throughout the clamp (Fig.
2d), with GIR lower in recuperated offspring (p < 0.01).
Furthermore, mean GIR during steady state was lower in
recuperated offspring compared with controls (p < 0.05;
Fig. 2e). Compared with baseline, plasma NEFA levels
were significantly lower during hyperinsulinaemia in both
groups (control: 0.44 ± 0.05 to 0.20 ± 0.04 mmol/l; recu-
perated: 0.27 ± 0.04 to 0.16 ± 0.04 mmol/l; p < 0.001 com-
pared with baseline); the percentage drop in NEFA levels
from baseline to hyperinsulinaemic steady state was not
significantly different between groups (control: 56.2% ±
5.3%; recuperated: 42.8% ± 6.6%).
Recuperated mice are resistant to the anorectic effects of
central insulin There was no difference in pre-surgery baseline
food intake over a 12 h period between control and recuper-
ated offspring (Fig. 3a). ICV insulin injection resulted in a
significant reduction in food intake in control mice during
the first 4 h compared with baseline (p < 0.01; Fig. 3b). This
was followed by hyperphagia compared with baseline food
intake from 12 to 20 h after food presentation (p < 0.05). In
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Fig. 2 Glucose and insulin sensitivity of control and recuperated off-
spring. (a) GTT (1 g/kg i.p. glucose injection) in offspring at 12 weeks
of age. p < 0.001 for overall effect ofmaternal diet and p < 0.01 for overall
effect of time, two-way ANOVA. (b) AUC of GTT. (c) Plasma glucose
levels during hyperinsulinaemic–euglycaemic clamp in offspring at
12 weeks of age. Insulin bolus represented by the vertical dashed line at
time 0. (d) GIR during hyperinsulinaemic–euglycaemic clamp study in
offspring at 12 weeks of age. Insulin bolus represented by the vertical
dotted line at time 0. p < 0.01 for overall effect of maternal diet and p <
0.001 for overall effect of time, two-way ANOVA. (e) GIR during
hyperinsulinaemic steady state. Solid line/white circles, control; dashed
line/black circles, recuperated. In (a, b), control n = 11, recuperated n = 6;
in (c–e), control n = 9, recuperated n = 8. In (a), *p < 0.05, post hoc test,
recuperated vs control; in (b, e), *p < 0.05, t test
Fig. 3 Effects of ICV insulin administration on food intake in control and
recuperated offspring. (a) Pre-surgery food intake of control (white cir-
cles) and recuperated (black circles) offspring, measured for the 12 h
period immediately before the ICV cannula was implanted. (b–c)
Cumulative food intake was measured at 2, 4, 12 and 20 h after food
presentation at baseline conditions (white bars) or after insulin injection
(0.4 μU; black bars) into the lateral ventricle of control offspring (b) and
recuperated offspring (c). Control n = 7; recuperated n = 5). *p < 0.05,
**p < 0.01, t test vs baseline
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contrast to control animals, there was no effect of insulin on
food intake compared with baseline in recuperated offspring
(Fig. 3c). There was no effect of insulin injection on body
weight in response to ICV insulin injection in either group
(data not shown).
Expression of insulin signalling pathway components in hy-
pothalamic nuclei Gene expression of components of the in-
sulin signalling pathway were measured in distinct hypotha-
lamic nuclei capable of sensing and integrating insulin signal-
ling into an alteration of food intake. There was no difference
in the expression of Insr (encoding the insulin receptor), Irs1
(encoding IRS1) or Irs2 (encoding IRS2) in the ARC, VMH
or PVH between control and recuperated offspring (Fig. 4a–
c). There was also no difference in the expression of Pik3cb
and P85α, which encode the catalytic and regulatory subunits
of PI3K, respectively, in any of the nuclei examined (Fig. 4a–
c). We next examined the expression of PTP1B (encoded by
Ptpn1), which is known to negatively regulate insulin signal-
ling in the hypothalamus [19]. There was a significant increase
in Ptpn1 expression in the ARC (p < 0.01; Fig. 4a) but not
PVH or VMH (Fig. 4b,c). Previous studies have shown that
PTP1B expression is increased by TNFα, the levels of which
are often associated with increased inflammation seen with
obesity [23]. However, there was no difference in serum
TNFα levels between control and recuperated offspring (con-
trol: 7.84 ± 0.52 ng/ml; recuperated: 9.06 ± 0.57 ng/ml) in the
present study.
There was no difference in the expression of the insulin
receptor in the ARC in recuperated offspring (Fig. 5a).
However, recuperated offspring showed increased levels of
IRS1 phosphorylated at Ser307 (P-IRS1; p < 0.01; Fig. 5b)
and decreased levels of the p110β catalytic subunit of PI3K
(p < 0.01; Fig. 5c) in the ARC. Antibody staining for each
protein, along with loading control, are shown in Fig. 5d.
Discussion
We used a rodent model to show that animals that undergo
IUGR followed by rapid postnatal catch-up growth display
whole-body insulin resistance in adulthood. This is associated
with peripheral insulin resistance, as demonstrated by the results
of the hyperinsulinaemic–euglycaemic clamps. Our findings
show, for the first time, that suboptimal nutrition during early
life can also lead to central insulin resistance, and identify a
novel mechanism in the ARC that may underpin this. Previous
rodent models have shown that raising neonates in small litters
disrupts energy homeostasis and causes insulin resistance in
neuronal cultures [24]. Therefore, the phenotype in recuperated
offspring could be due either to the low birthweight caused by
IUGR or to the accelerated neonatal growth caused by the small
litter rearing, or indeed a combination of the two (as in the
human situation where most low birthweight babies will expe-
rience postnatal catch-up growth).
Recuperated offspring had higher glucose levels during the
GTT, indicating decreased glucose tolerance, in agreement
with other rodent and larger mammal models of nutritional
programming [25–28]. This glucose intolerance is likely at-
tributed to reduced insulin sensitivity, as these mice also re-
quired a lower GIR to maintain blood glucose during the
hyperinsulinaemic–euglycaemic clamp. We have previously
reported that recuperated offspring show molecular defects
in expression of key components of the insulin signalling
pathway in peripheral tissues [16, 17], thus this may contrib-
ute to the insulin resistance shown in the clamp. Despite no
changes in total body weight or adiposity, recuperated off-
spring showed an increase in epididymal fat mass. This is in
Fig. 4 Insulin-signalling-related gene expression in the ARC, PVH and
VMH of control and recuperated offspring. Expression of insulin-signal-
ling-related genes encoding insulin receptor (Insr), IRS1 (Irs1), IRS2
(Irs2), PI3K catalytic subunit (Pik3cb), PI3K regulatory subunit (P85α)
and PTP1B (Ptpn1) in the (a) ARC, (b) PVH and (c) VMH of 12-week-
old control (white bars) and recuperated (black bars) offspring. mRNA
levels were normalised to housekeeping gene Sdha, expressed as relative
to control. Control n = 7; recuperated n = 8. **p < 0.01, t test vs control
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agreement with previous reports from human studies that in-
fants born SGA have higher central adiposity, despite a compa-
rable BMI to infants born at a normal weight [29]. Recuperated
offspring demonstrated reduced EE, which may predispose
them to an increase in body weight, as well as total adiposity,
as they get older. Our data from indirect calorimetry also sug-
gest different fuel usage in recuperated offspring as their RER
was lower, indicating that fats are preferentially used as a sub-
strate for energy generation compared with carbohydrates.
In this study, control mice were sensitive to the anorectic
effects of ICV insulin; food intake was significantly reduced 2
and 4 h after food presentation when insulin was administered
into the lateral ventricle. This is in agreement with several stud-
ies showing the anorectic effects of central insulin administra-
tion, either intranasally [30] or directly to the brain via injection
[31–33]. However, there was no effect on food intake in recu-
perated mice, showing that these animals were resistant to the
anorectic effects of exogenous insulin and suggesting central
insulin resistance. Studies in both rodents and humans have
shown that central insulin resistance contributes to the patholo-
gy of whole-body insulin resistance [10, 34]. Therefore, the
central insulin resistance observed in recuperated offspring
could contribute to the whole-body insulin resistance observed.
Although central insulin resistance is associated with obesity
and type 2 diabetes [35, 36], it is usually thought of as a con-
sequence of chronic hyperinsulinaemia and obesity rather than
a cause. However, it has been shown in rodents fed a high-fat
diet (HFD) that resistance to ICV insulin can occur within a
matter of days and before an increase in adiposity [37]. In this
previous study of the effects of an acute HFD, central insulin
resistance was associated with elevated NEFA. NEFA are able
to cross the blood–brain barrier and activate inflammatory path-
ways, resulting in hypothalamic insulin resistance [38].
Interestingly, in our study, recuperated offspring develop central
insulin resistance despite being maintained on a regular chow
diet and in the absence of elevated NEFA levels. The presence
of insulin resistance in the absence of frank obesity, elevated
NEFA or hyperinsulinaemia raises the possibility that changes
to insulin sensitivity in these mice are programmed during early
life. There is evidence from human studies that the fetal brain
responds to changes in maternal glucose in insulin-sensitive but
not insulin-resistant mothers, suggesting that fetuses of insulin-
resistant mothers are themselves insulin resistant in utero [39].
Furthermore, babies from obese pregnancies display insulin
resistance at birth [40]. Therefore, it is possible that in circum-
stances of altered metabolic state in the mother during pregnan-
cy, insulin resistance programmed during the perinatal period is
causative of further metabolic dysfunction, rather than being a
consequence of it.
Our previous studies in adipose tissue and muscle from
recuperated offspring [16, 17] and from humans with a low
birthweight [14] have demonstrated changes in expression of
key insulin signalling proteins. One of the biggest effects is
observed on levels of the p110β catalytic subunit of PI3K. In
humans and rodents, the reduced expression occurs at the
post-transcriptional level, with no differences being observed
at the mRNA level. Here, for the first time, we demonstrate
that this protein is also present at substantially reduced levels
in the ARC of recuperated animals. In addition to reduced
p110β, we observed an increase in serine phosphorylation of
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Fig. 5 Levels of key insulin-signalling proteins in the ARC of control and
recuperated offspring. Expression of insulin signalling pathway proteins
(a) insulin receptor (IRβ), (b) phospho-IRS1 (Ser307) and (c) p110β
catalytic subunit of PI3K in the ARC of 12-week-old control (white
circles) and recuperated (black circles) offspring (relative protein levels
normalised to whole protein loading [as assessed by Ponceau stain],
expressed as percentage of control). (d) Western blot images of IRβ, p-
IRS1 and p110β and loading controls. Control n = 6; recuperated n = 6.
**p < 0.01, t test
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IRS-1. Ptpn1 mRNA levels were also increased in the ARC
from recuperated animals. Whole-body or neuronal deletion
of Ptpn1 improves insulin sensitivity [19]. Therefore, all of
these changes could contribute to the lack of anorectic re-
sponse to ICV insulin in recuperated offspring. As intact in-
sulin signalling in the ARC is essential for maintaining energy
homeostasis, ARC insulin resistance also likely contributes
strongly to the peripheral insulin resistance observed in the
hyperinsulinaemic–euglycaemic clamps in recuperated off-
spring. A recent study has shown that insulin signals through
POMC neurons to cause browning of white adipose tissue and
therefore increased EE [41]. Abrogation of insulin signalling
by overexpression of PTP1B in the ARC inhibits this process.
Conversely, mice with a global knockout of Ptpn1 have in-
creased EE [42]. Therefore, the increased Ptpn1 expression
we observed in the ARC may also contribute to the decreased
EE that we observed in recuperated offspring.
The specific increase in Ptpn1 expression in the ARC but
not in other hypothalamic areas examined suggests selective
insulin resistance. Selective ARC resistance to leptin has been
reported previously as a consequence of diet-induced obesity
[43]. To our knowledge, there have not been reports of selec-
tive insulin resistance within the different nuclei of the hypo-
thalamus. However, selective hypothalamic insulin resistance
has been reported in humans, as obese men show responses in
cognitive areas but not hypothalamic areas of the brain after
intranasal insulin administration [44].
We have previously shown that, compared with control an-
imals, recuperated animals have a reduced lifespan and show
signs of accelerated cellular ageing [45]. Central insulin respon-
siveness is decreased with ageing [46], which may in part be
due to increased negative regulation of insulin signalling trans-
duction. The expression of PTP1B, as well as other phospha-
tases that negatively regulate insulin signalling, is increased
with ageing and has been suggested as an underlying mecha-
nism of age-associated insulin resistance [47–49]. The increase
in Ptpn1 expression in the ARC and central insulin resistance
could therefore be further examples of accelerated ageing in
mice that have undergone IUGR followed by catch-up growth.
In conclusion, our results show that in mice, undernutrition
during the in utero period followed by rapid neonatal catch-up
growth causes central insulin resistance and peripheral insulin
resistance. This has important implications for the long-term
health of an individual. A recent study has shown that humans
with central insulin resistance have a reduced capacity to lose
weight by lifestyle intervention [50]. Furthermore, it is unclear
whether primary treatments for improving insulin sensitivity,
such as thiazolidinediones and metformin, can cross the
blood–brain barrier and improve brain insulin sensitivity.
Therefore, humans with central insulin resistance have a re-
duced capacity for metabolic improvements via both lifestyle
and pharmaceutical interventions. These findings in mice, if
extrapolated to humans, suggest that individuals exposed to a
suboptimal early environment may be less responsive to cur-
rently available interventions.
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